Home > National Drug Code (NDC) > Triamterene and Hydrochlorothiazide

Triamterene and Hydrochlorothiazide - 0527-1632-10 - (Triamterene and Hydrochlorothiazide)

Alphabetical Index


Drug Information of Triamterene and Hydrochlorothiazide

Product NDC: 0527-1632
Proprietary Name: Triamterene and Hydrochlorothiazide
Non Proprietary Name: Triamterene and Hydrochlorothiazide
Active Ingredient(s): 25; 37.5    mg/1; mg/1 & nbsp;   Triamterene and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Triamterene and Hydrochlorothiazide

Product NDC: 0527-1632
Labeler Name: Lannett Company, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA201407
Marketing Category: ANDA
Start Marketing Date: 20111212

Package Information of Triamterene and Hydrochlorothiazide

Package NDC: 0527-1632-10
Package Description: 1000 CAPSULE in 1 BOTTLE (0527-1632-10)

NDC Information of Triamterene and Hydrochlorothiazide

NDC Code 0527-1632-10
Proprietary Name Triamterene and Hydrochlorothiazide
Package Description 1000 CAPSULE in 1 BOTTLE (0527-1632-10)
Product NDC 0527-1632
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Triamterene and Hydrochlorothiazide
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20111212
Marketing Category Name ANDA
Labeler Name Lannett Company, Inc.
Substance Name HYDROCHLOROTHIAZIDE; TRIAMTERENE
Strength Number 25; 37.5
Strength Unit mg/1; mg/1
Pharmaceutical Classes Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Triamterene and Hydrochlorothiazide


General Information